Cancer prevention research
that doesn't insult your intelligence.
We analyze clinical trials, meta-analyses, and emerging evidence on cancer prevention and repurposed treatments. Every claim gets an evidence grade. No supplements to sell. No miracle cures. Just research.
Our Evidence Grading System
Every compound and intervention gets a grade based on the quality of human clinical evidence, not animal studies or test tubes.
Latest Research
High-Dose IV Vitamin C: The Trial That Doubled Survival
A Phase II RCT doubled overall survival in metastatic pancreatic cancer. We break down the Iowa trial, mechanism, and what it means.
⭐ Grade A: Strong EvidenceMebendazole: The $5 Cancer Drug
An FDA-approved dewormer with Phase I/II trial data in glioblastoma and colorectal cancer. Crosses the blood-brain barrier.
🔬 Grade B: PromisingThe Galleri Test: Is $950/yr Worth It?
A blood test that detects 50 cancer types. The PATHFINDER 2 trial showed 7x cancer detection. We analyze what that actually means.
⭐ Grade A: Strong EvidenceHigh-Dose Melatonin: The 34% Mortality Reduction
Meta-analysis of 8 RCTs shows melatonin at 10-20mg (not sleep doses) reduced cancer mortality by 34%. No toxicity ever established.
🔬 Grade B: PromisingWhy Metformin Failed for Cancer
The MA.32 trial (3,649 patients) killed the metformin-cancer hypothesis. HR 1.01. We explain what went wrong with the observational data.
⚠️ Grade D: Weak / MixedThe Anti-Cancer Protocol: Daily, Weekly, Monthly
An evidence-ranked stack of interventions from free (fasting, exercise) to prescription (rapamycin). Every item graded.
⭐ Grade A: Strong EvidenceNew research reviews every month.
We track clinical trials, emerging compounds, and AI-driven cancer discoveries. Get updates when we publish new evidence reviews.